期刊
CELLS
卷 11, 期 16, 页码 -出版社
MDPI
DOI: 10.3390/cells11162601
关键词
SALL4; neoplasm; drug development; molecular glue
类别
资金
- Singapore Ministry of Health's National Medical Research Council (Singapore Translational Research (STaR) Investigator Award) [STaR18nov-0002]
- Singapore Ministry of Education under its Research Centers of Excellence initiative
- NIH/NCI [R35CA197697]
- NIH/NHLBI [P01HL131477-01A1]
- Xiu research fund
SALL4 is a critical factor for self-renewal ability and pluripotency of stem cells, and is tightly related to cancer occurrence and metastasis. It is an ideal target for cancer therapy due to its high expression in cancer cells and silence in adult tissues. However, targeting SALL4 faces various challenges.
Spalt-Like Transcription Factor 4 (SALL4) is a critical factor for self-renewal ability and pluripotency of stem cells. On the other hand, various reports show tight relation of SALL4 to cancer occurrence and metastasis. SALL4 exerts its effects not only by inducing gene expression but also repressing a large cluster of genes through interaction with various epigenetic modifiers. Due to high expression of SALL4 in cancer cells and its silence in almost all adult tissues, it is an ideal target for cancer therapy. However, targeting SALL4 meets various challenges. SALL4 is a transcription factor and designing appropriate drug to inhibit this intra-nucleus component is challenging. On the other hand, due to lack of our knowledge on structure of the protein and the suitable active sites, it becomes more difficult to reach the appropriate drugs against SALL4. In this review, we have focused on approaches applied yet to target this oncogene and discuss the potential of degrader systems as new therapeutics to target oncogenes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据